MIRM MIRM

Mirum Pharmaceuticals Stock Price

24.50
-3.85 (-13.58%)
24.50
Volume 426,157
Bid Price 24.10
Ask Price 24.70
News (2)
Day High 28.635

Low
12.82

52 Week Range

High
30.545

Day Low 26.81
Company Name Stock Ticker Symbol Market Type
Mirum Pharmaceuticals Inc MIRM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-3.85 -13.58% 24.50 18:37:28
Open Price Low Price High Price Close Price Prev Close
28.12 26.81 28.635 27.49 28.35
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
6,725 426,157 $ 27.46 $ 11,700,302 - 12.82 - 30.545
Last Trade Time Type Quantity Stock Price Currency
18:37:28 75 $ 24.50 USD

Period:

Draw Mode:

Mirum Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 802.42M 32.75M 18.88M $ 19.14M $ - -2.77 -13.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 148.91k 0.90%

more financials information »

Mirum Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MIRM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week22.6930.54521.5027.25418,3841.817.98%
1 Month24.1730.54521.1225.54223,5300.331.37%
3 Months24.1930.54517.5722.93256,6640.311.28%
6 Months21.5630.54517.5723.13213,9872.9413.64%
1 Year14.6930.54512.8220.32196,7689.8166.78%
3 Years15.0030.5456.512619.24150,0129.5063.33%
5 Years13.0030.5456.512619.14149,54911.5088.46%

Mirum Pharmaceuticals Description

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.


Your Recent History
NASDAQ
MIRM
Mirum Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now